Hoenigl, Martin

COVID-19-associated fungal infections

Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology

Antifungal resistance and susceptibilityCOVID-19 Clinical Research Studies

Cited by 482

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 467

Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap

Daneshnia, F., de Almeida Júnior, J. N., Ilkit, M., Lombardi, L., Perry, A. M., Gao, M., Nobile, C. J., Egger, M., Perlin, D. S., Zhai, B., et al. (2023) · The Lancet Microbe

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 257

Performance of Galactomannan, Beta- d -Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis

Hoenigl, M., Prattes, J., Spiess, B., Wagner, J., Prueller, F., Raggam, R. B., Posch, V., Duettmann, W., Hoenigl, K., Wölfler, A., et al. (2014) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 233

Breakthrough invasive fungal infections: Who is at risk?

Jenks, J. D., Cornely, O. A., Chen, S. C. ‐., Thompson, G. R., & Hoenigl, M. (2020) · Mycoses

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 191

Diagnosing COVID-19-associated pulmonary aspergillosis

Verweij, P. E., Gangneux, J.-P., Bassetti, M., Brüggemann, R. J. M., Cornely, O. A., Koehler, P., Lass-Flörl, C., van de Veerdonk, F. L., Chakrabarti, A., & Hoenigl, M. (2020) · The Lancet Microbe

Antifungal resistance and susceptibilityCOVID-19 Clinical Research Studies

Cited by 181

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

Hoenigl, M., Salmanton-García, J., Egger, M., Gangneux, J.-P., Bicanic, T., Arikan-Akdagli, S., Alastruey-Izquierdo, A., Klimko, N., Barac, A., Özenci, V., et al. (2023) · The Lancet Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 152

Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings

Denning, D. W., Page, I. D., Chakaya, J., Jabeen, K., Jude, C. M., Cornet, M., Alastruey-Izquierdo, A., Bongomin, F., Bowyer, P., Chakrabarti, A., et al. (2018) · Emerging Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 144

Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study

Salmanton-García, J., Cornely, O. A., Stemler, J., Barać, A., Steinmann, J., Siváková, A., Akalin, E. H., Arikan-Akdagli, S., Loughlin, L., Toscano, C., et al. (2024) · Journal of Infection

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 127

Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives

Alastruey-Izquierdo, A., Cadranel, J., Flick, H., Godet, C., Hennequin, C., Hoenigl, M., Kosmidis, C., Lange, C., Munteanu, O., Page, I., et al. (2018) · Respiration

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 126

Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples

Heldt, S., Prattes, J., Eigl, S., Spiess, B., Flick, H., Rabensteiner, J., Johnson, G., Prüller, F., Wölfler, A., Niedrist, T., et al. (2018) · Journal of Infection

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 110

Epidemiology of Invasive Candidiasis

Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 109

Let’s talk about sex characteristics—as a risk factor for invasive fungal diseases.

Egger, M., Hoenigl, M., Thompson, G. R., Carvalho, A., & Jenks, J. D. (2022) · Mycoses

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 82

An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections

Jenks, J. D., White, P. L., Kidd, S. E., Goshia, T., Fraley, S. I., Hoenigl, M., & Thompson, G. R. (2023) · Expert Review of Molecular Diagnostics

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 61

Race and ethnicity: Risk factors for fungal infections?

Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 55

Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignancies

Jenks, J. D., Mehta, S. R., Taplitz, R., Law, N., Reed, S. L., & Hoenigl, M. (2019) · Journal of Infection

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 54

Signs or symptoms of acute HIV infection in a cohort undergoing community-based screening.

Hoenigl, M., Green, N., Camacho, M., Gianella, S., Mehta, S. R., Smith, D. M., & Little, S. J. (2016) · Emerging infectious diseases

HIV Research and TreatmentHIV/AIDS Research and Interventions

Cited by 54

Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis

Hoenigl, M., Egger, M., Price, J., Krause, R., Prattes, J., & White, P. L. (2023) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 51

Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement

Jenks, J. D., Gangneux, J.-P., Schwartz, I. S., Alastruey-Izquierdo, A., Lagrou, K., Thompson III, G. R., Lass-Flörl, C., Hoenigl, M., & Investigators, E. C. O. M. M. (. C. (2020) · Journal of Fungi

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 44

Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis

Salzer, H. J. F., Prattes, J., Flick, H., Reimann, M., Heyckendorf, J., Kalsdorf, B., Obersteiner, S., Gaede, K. I., Herzmann, C., Johnson, G. L., et al. (2018) · Frontiers in Microbiology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 41